WNT9A
Basic information
Region (hg38): 1:227918656-227947932
Previous symbols: [ "WNT14" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WNT9A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 3 | 1 |
Variants in WNT9A
This is a list of pathogenic ClinVar variants found in the WNT9A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-227921526-T-C | not specified | Uncertain significance (Jun 29, 2022) | ||
1-227921532-T-C | not specified | Uncertain significance (May 13, 2024) | ||
1-227921620-G-T | not specified | Uncertain significance (Oct 11, 2021) | ||
1-227921627-G-A | not specified | Uncertain significance (May 17, 2023) | ||
1-227921672-C-T | not specified | Uncertain significance (Apr 17, 2024) | ||
1-227921680-C-A | not specified | Uncertain significance (May 24, 2024) | ||
1-227921715-C-A | not specified | Uncertain significance (Oct 05, 2021) | ||
1-227921762-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
1-227921771-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
1-227921870-G-A | not specified | Uncertain significance (Apr 18, 2024) | ||
1-227921915-G-A | not specified | Uncertain significance (May 27, 2022) | ||
1-227921934-T-A | not specified | Uncertain significance (May 24, 2024) | ||
1-227921987-C-A | not specified | Uncertain significance (Jan 24, 2024) | ||
1-227924188-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
1-227924197-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
1-227924222-C-T | Likely benign (Dec 01, 2022) | |||
1-227924319-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
1-227924333-C-T | Benign (Jul 13, 2018) | |||
1-227925372-C-T | Likely benign (Mar 01, 2023) | |||
1-227925373-G-A | not specified | Uncertain significance (Jul 17, 2023) | ||
1-227925388-G-A | not specified | Uncertain significance (Apr 06, 2022) | ||
1-227925398-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
1-227925403-A-C | not specified | Uncertain significance (Feb 10, 2022) | ||
1-227925409-C-T | not specified | Uncertain significance (Jan 11, 2023) | ||
1-227925433-C-T | not specified | Uncertain significance (Oct 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WNT9A | protein_coding | protein_coding | ENST00000272164 | 4 | 29243 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.912 | 0.0876 | 125673 | 0 | 2 | 125675 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.20 | 185 | 237 | 0.781 | 0.0000171 | 2300 |
Missense in Polyphen | 77 | 109.77 | 0.70149 | 1024 | ||
Synonymous | 0.00502 | 99 | 99.1 | 0.999 | 0.00000703 | 754 |
Loss of Function | 2.97 | 1 | 12.2 | 0.0818 | 6.72e-7 | 142 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000293 | 0.0000293 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Functions in the canonical Wnt/beta- catenin signaling pathway. Required for normal timing of IHH expression during embryonic bone development, normal chondrocyte maturation and for normal bone mineralization during embryonic bone development. Plays a redundant role in maintaining joint integrity. {ECO:0000250|UniProtKB:O42280, ECO:0000250|UniProtKB:Q8R5M2}.;
- Pathway
- Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);EMT transition in Colorectal Cancer;Signaling by GPCR;Signaling by WNT;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;WNT ligand biogenesis and trafficking;GPCR signaling-G alpha i;Wnt Canonical;TCF dependent signaling in response to WNT;Wnt Mammals
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.88
Haploinsufficiency Scores
- pHI
- 0.0893
- hipred
- Y
- hipred_score
- 0.699
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.538
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wnt9a
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype; craniofacial phenotype;
Zebrafish Information Network
- Gene name
- wnt9a
- Affected structure
- chondrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- mitotic cell cycle checkpoint;cell-cell signaling;multicellular organism development;negative regulation of cell population proliferation;regulation of signaling receptor activity;Wnt signaling pathway;neuron differentiation;negative regulation of chondrocyte differentiation;embryonic forelimb morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cell fate commitment;positive regulation of cell differentiation;positive regulation of smoothened signaling pathway;embryonic skeletal system morphogenesis;canonical Wnt signaling pathway;iris morphogenesis;cornea development in camera-type eye;cellular response to retinoic acid;embryonic skeletal joint development
- Cellular component
- extracellular region;extracellular space
- Molecular function
- frizzled binding;receptor ligand activity